ENDV
Price:
$0.0001
Market Cap:
$31.88K
Endonovo Therapeutics, Inc., a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine applications. The company's primary offering is SofPulse, an advanced non-invasive therapeutic device that employs electroceutical technology. SofPulse is engineered to provide palliative relief for various conditions, including soft tissue injuries, chronic wounds, and post-operative pain and edema. Beyond these applications, Endonovo's electroceutical medical device is also utilized in treating a broad spectrum of other ailments. These include inflammation, various types of wounds, cardiovasc...[Read more]
Industry
Biotechnology
IPO Date
2012-11-15
Stock Exchange
OTC
Ticker
ENDV
According to Endonovo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 6.45%. This represents a change of 182.82% compared to the average of 2.28% of the last 4 quarters.
The mean historical ROE of Endonovo Therapeutics, Inc. over the last ten years is 38.53%. The current 6.45% ROE has changed -83.26% with respect to the historical average. Over the past ten years (40 quarters), ENDV's ROE was at its highest in in the March 2017 quarter at 59.43%. The ROE was at its lowest in in the March 2020 quarter at -38.94%.
Average
38.53%
Median
38.09%
Minimum
-28.73%
Maximum
113.19%
Discovering the peaks and valleys of Endonovo Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 615.20%
Maximum Annual ROE = 113.19%
Minimum Annual Increase = -150.03%
Minimum Annual ROE = -28.73%
| Year | ROE | Change |
|---|---|---|
| 2025 | 7.54% | -27.79% |
| 2024 | 10.44% | -136.33% |
| 2023 | -28.73% | -150.03% |
| 2022 | 57.41% | 191.67% |
| 2021 | 19.68% | 615.20% |
| 2020 | 2.75% | -96.74% |
| 2019 | 84.45% | 49.47% |
| 2018 | 56.50% | -50.09% |
| 2017 | 113.19% | 82.32% |
| 2016 | 62.09% | -7.23% |
The current ROE of Endonovo Therapeutics, Inc. (ENDV) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.58%
5-year avg
13.27%
10-year avg
38.53%
Endonovo Therapeutics, Inc.’s ROE is less than Itoco Inc. (199.43%), less than Baseline Productions, Inc. (166.21%), less than GeneLink, Inc. (147.34%), less than Medical Imaging Corp. (73.60%), less than Amarantus BioScience Holdings, Inc. (21.36%), greater than Affymax, Inc. (-420.95%), less than Nutranomics, Inc. (99.34%), less than CNBX Pharmaceuticals Inc. (14.50%), greater than Veritas Farms, Inc. (-243.84%), greater than West Island Brands Inc. (-99.72%),
| Company | ROE | Market cap |
|---|---|---|
| 199.43% | $17.05K | |
| 166.21% | $74.38K | |
| 147.34% | $10.60K | |
| 73.60% | $31.91K | |
| 21.36% | $36.84K | |
| -420.95% | $41.24K | |
| 99.34% | $816.23K | |
| 14.50% | $18.50K | |
| -243.84% | $16.39K | |
| -99.72% | $60.06K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Endonovo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Endonovo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Endonovo Therapeutics, Inc.'s ROE?
How is the ROE calculated for Endonovo Therapeutics, Inc. (ENDV)?
What is the highest ROE for Endonovo Therapeutics, Inc. (ENDV)?
What is the 3-year average ROE for Endonovo Therapeutics, Inc. (ENDV)?
What is the 5-year average ROE for Endonovo Therapeutics, Inc. (ENDV)?
How does the current ROE for Endonovo Therapeutics, Inc. (ENDV) compare to its historical average?